Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes

BACKGROUND: Basal continuous subcutaneous insulin infusion (CSII) therapy at a fixed rate may effectively improve glycemic control in patients with type 2 diabetes when oral antidiabetic treatment fails. Regimens of simple constant subcutaneous delivery of insulin may provide theoretical advantages...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Parkner, Tina, Laursen, Torben, Chen, Jian-Wen, Møller, Marianne K., Thomsen, Henrik F., Jørgensen, Christina, Smedegaard, Jørgen S., Lauritzen, Torsten, Christiansen, Jens S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Diabetes Technology Society 2007
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2769649/
https://ncbi.nlm.nih.gov/pubmed/19885138
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky